Mice Model Market Size By Mice Type (Inbred, Outbred, Knockout, Hybrid), By Technology (CRISPR, Microinjection, Embryonic Stem Cell, Nuclear Transfer), By Application (Research & Development {Infectious Disease, Immunological Disease, Cancer, Cardiovascular Diseases, Diabetes, Genetic Diseases, Neurological Diseases}, Production and Quality Control, Academics), By Use (Human, Veterinary), By End-use (Companies {Pharmaceutical, Biotechnology, Cosmetics}, Organizations {Government, Non-Government}, Academic And Research Institutes, Contract Research Organizations), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025

Published Date: Dec 2019  |  Report ID: GMI4473  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 450   |   Base Year: 2018




Summary Table of Contents Industry Coverage Methodology

Industry Trends

Mice Model Market size exceeded USD 6.9 billion in 2019 and is poised to grow at over 7.7% CAGR between 2019 and 2025. Growing use of mice for research purpose will augment the market growth.
 

Mice have rapidly overtaken rats as the preferred animal research model leading to increased mice model market demand. Mice are further used in sensory, aging, behavioural, nutrition and genetic studies along with testing anti-craving medication that could potentially end drug addiction. However, growing concern for the wellbeing of animals and rising awareness pertaining to animal rights will hinder the industry growth.
 

Mice Model Market

Get more details on this report - Request Free Sample PDF
 

Growing demand for mice model in cancer research for understanding the genetic basis of tumour development and cancer progression is boosting the mice model market revenue. Mice model are also used to check the efficacies of different anti-cancerous agents. Some of the most influential cancer drugs in the field trace their origins to discoveries with mice. Mice model have brightened the future of cancerous treatment and cure. Studies with mice have highlighted a variety of exciting potential therapies of cancer, including a vaccine to prevent breast cancer, tiny nanoparticles that delivers toxins to ovarian cancer cells and phototherapy that delivers light to destroy deep tumours. Other factors that have fostered the adoption of mice model are its easy handling and low maintenance.
 

Mice Model Market Report Coverage
Report Coverage Details
Base Year: 2018 Market Size in 2018: USD 6.9 Billion
Historical Data for: 2014 to 2017 Forecast Period: 2019 to 2025
Forecast Period 2019 to 2025 CAGR: 7.7% 2025 Value Projection: USD 11.7 Billion
Pages: 450 Tables, Charts & Figures: 387
Geographies covered (30): U.S., Canada, Germany, UK, France, Spain, Italy, Switzerland, Netherlands, Czech Republic, Poland, Belgium, Finland, Hungary, Denmark, Ireland, Sweden, China, Japan, Australia, South Korea, New Zealand, Taiwan, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE, Israel
Segments covered: Mice type, Technology, Applications, Use, End-use
Companies covered (8): Envigo, genOway, Charles River, Transviragen Inc., Janvier Labs, Taconic Biosciences Inc., Transpogen Biopharmaceutical, Inc. and The Jackson Laboratory.
Growth Drivers:
  • Rise in the advancements of gene editing tools
  • Rising demand for humanized mice models
  • Physiological similarities between human and mice
  • Growing consumption of personalized medicine in developing and developed countries
Pitfalls & Challenges:
  • Ongoing developments of alternative methods to animal testing
  • Strict regulations and guidelines
  • Growing opposition on mice testing by several organizations

Get more details on this report - Request Free Sample PDF
 

Increasing usage of knockout mice model to study various complex disorders

Knockout mice model market is expected to witness a lucrative growth of 9.5% through 2025. The high growth rate is owing to increase in usage of knockout mice model in studying and modelling different kinds of cancer, diabetes, lifestyle disorders, neurological disorders, and heart diseases.
 

The other factor that is contributing to the adoption of knockout mice model is the information that these models offer to the researchers regarding similar gene that causes or contributes to specific diseases in humans. These models are also further extensively used in the study of several malaria-induced pathologies.
 

CRISPR, a gene editing technology is anticipated to drive the mice model market growth

U.S. Mice Model Market By Technology

Get more details on this report - Request Free Sample PDF
 

CRISPR technology segment is predicted to expand at 8.1% CAGR during the forecast period due to several factors such as generating custom knockouts & point mutations at significant cost reduction and reduces timelines compared to traditional gene targeting methods. CRISPR technology is further expected to pave the way for large number of new genetic mice model that is mainly used for oncology & neuroscience research.
 

Growing application of mice model in research and development

Research and development application segment in the mice model market accounted for around USD 4.9 billion in 2018. Rising demand for mice model in R&D activity is significantly growing with each passing year. Mice model are considered as the best models for understanding the pathogenic mechanism of Alzheimer’s disease and offers therapeutic approaches to tackle clinical progression of the disease.
 

Application of mice model in human diseases lead to effective results

The use of animal testing for human research held substantial mice model market share in 2018 and is projected to register around 7.7% growth rate from 2019 to 2025. The adoption of mice model for understanding of several diseases such as cancer, cardiovascular diseases, diabetes, and neurological diseases is fostering the segment growth. Furthermore, genetic similarity between humans and mice is one of the factors that is contributing to the market revenue.
 

Ongoing research and development activities in pharma industry will enhance the mice model market growth

The companies segment value was around USD 4.3 billion in 2018 on account of increase in research and development activities in biotechnology and pharmaceutical industry. The demand for mice as a preclinical animal model is owing to several advantages that the mice model possesses over other animal models. With a short gestation period of twenty days, inheritance studies are accomplished in a shorter time frame than other species with longer gestation period.
 

Presence of key players and rapidly increasing animal testing in biomedical research in the U.S.

Europe Mice Model Market By Country

Get more details on this report - Request Free Sample PDF
 

U.S. dominated the North America mice model market with revenue of around USD 5.7 billion in the year 2018. Presence of major pharmaceutical and biotechnology companies, along with established research and development institutes will enhance the industry growth in the country. For instance, in the U.S. each year around 90 million mice are used for research purposes.
 

The ongoing research on cancer and neurological disorders is propelling the market growth in the country. For instance, in 2019, according to the Alzheimer’s Association, Alzheimer’s is the sixth leading cause of death in the U.S. and around 5.8 million Americans living with Alzheimer’s. Furthermore, after every 65 second an individual in the country develops is diagnosed with the disease.
 

Execution of strategies such as partnerships and collaborations by major industry players

Some of the leading players in the mice model market include Charles River, Envigo, genOway, Transviragen Inc., Janvier Labs, Taconic Biosciences Inc. and Transpogen Biopharmaceutical, Inc. These players have been engaging into partnerships and collaborations, acquisitions & mergers to increase the product portfolio and reinforce their market position.
 

The mice model market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2014 to 2025, for the following segments:
 

Market, By Mice Type

  • Inbred
  • Outbred
  • Knockout
  • Hybrid
  • Others

Market, By Technology

  • CRISPR
  • Microinjection
  • Embryonic Stem Cell Injection
  • Nuclear Transfer
  • Others

Market, By Application

  • Research and Development
    • Infectious Disease
    • Immunological Diseases
    • Cancer
    • Cardiovascular Diseases
    • Diabetes
    • Genetic Diseases
    • Neurological Diseases
    • Others
  • Production and Quality Control
  • Academics
  • Others

Market, By Use

  • Human
  • Veterinary

Market, By End-use

  • Companies
    • Pharmaceutical
    • Biotechnology
    • Cosmetics
    • Others
  • Organisations
    • Government
    • Non-government
  • Academic and Research Institutes
  • Contract Research Organizations (CROs)

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Switzerland
    • Netherlands
    • Czech Republic
    • Poland
    • Belgium
    • Finland
    • Hungary
    • Denmark
    • Ireland
    • Sweden
  • Asia Pacific
    • China
    • Japan
    • Australia
    • South Korea
    • New Zealand
    • Taiwan
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Israel
       

Frequently Asked Questions (FAQ) :

The market size of mice model exceeded USD 6.9 billion in 2018.
The industry share of mice model is poised to grow at over 7.7% CAGR between 2019 and 2025.
Some of the leading market players include Charles River, Envigo, genOway, Transviragen Inc., Janvier Labs, Taconic Biosciences Inc. and Transpogen Biopharmaceutical, Inc.
U.S. dominated the North America market with revenue of around USD 5.7 billion in the year 2018. Presence of major pharmaceutical and biotechnology companies, along with established research and development institutes will enhance the industry growth in the country.

Buy Now

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Premium Report Details

  • Published Date: Dec 2019
  • Pages: 450
  • Tables: 376
  • Charts / Figures: 11
  • Companies covered: 8
  • Countries covered: 30

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

GMIPulse, our report store

We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X